Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDC vs MRNA✓SelectedUSD · MRNAWDC vs MRNA performance historyLatest closeAs of+1.72%11/18
Stock and ETF performance explorer

WDC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+587.9%
MRNA return
-20.0%
Excess return
+607.9%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.7%-4.8%+6.6%+2.0%
7D-8.0%-20.9%+12.9%-6.7%
30D-18.2%-13.3%-4.9%-17.5%
3M-41.9%+212.6%-254.5%-48.5%
6M-37.1%+309.0%-346.2%-48.0%
YTD+67.5%+567.3%-499.8%+25.3%
1Y+88.9%+689.7%-600.8%+36.8%
3Y+721.8%+157.4%+564.4%+575.6%
5Y+587.9%-21.7%+609.6%+515.9%
All+587.9%-20.0%+607.9%+515.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling